In breast cancer, a recently identified splice variant called SRC-3Delta4 has been found to act as an adaptor protein between EGFR and its downstream signaling molecule FAK to coordinately regulate EGF-induced cell migration, and overexpression of this KAT isoform leads to enhanced breast cancer metastasis to the lung [89]. Here, EGFR is linked to breast carcinoma.